- Home
- VRAX vs AYRO Comparison
VRAX vs AYRO Comparison
Compare VRAX & AYRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRAX
- AYRO
- Stock Information
- Founded
- VRAX 2013
- AYRO 2017
- Country
- VRAX United Kingdom
- AYRO United States
- Employees
- VRAX N/A
- AYRO N/A
- Industry
- VRAX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- AYRO Telecommunications Equipment
- Sector
- VRAX Health Care
- AYRO Consumer Discretionary
- Exchange
- VRAX Nasdaq
- AYRO Nasdaq
- Market Cap
- VRAX 4.7M
- AYRO 4.3M
- IPO Year
- VRAX 2022
- AYRO N/A
- Fundamental
- Price
- VRAX $0.98
- AYRO $0.42
- Analyst Decision
- VRAX Strong Buy
- AYRO
- Analyst Count
- VRAX 1
- AYRO 0
- Target Price
- VRAX $3.00
- AYRO N/A
- AVG Volume (30 Days)
- VRAX 67.1K
- AYRO 339.9K
- Earning Date
- VRAX 02-05-2025
- AYRO 05-14-2025
- Dividend Yield
- VRAX N/A
- AYRO N/A
- EPS Growth
- VRAX N/A
- AYRO N/A
- EPS
- VRAX N/A
- AYRO N/A
- Revenue
- VRAX $84,872.00
- AYRO $5,426.00
- Revenue This Year
- VRAX $5,169.18
- AYRO N/A
- Revenue Next Year
- VRAX $66.97
- AYRO N/A
- P/E Ratio
- VRAX N/A
- AYRO N/A
- Revenue Growth
- VRAX 7.03
- AYRO N/A
- 52 Week Low
- VRAX $0.82
- AYRO $0.34
- 52 Week High
- VRAX $9.00
- AYRO $0.96
- Technical
- Relative Strength Index (RSI)
- VRAX 44.60
- AYRO 44.44
- Support Level
- VRAX $0.91
- AYRO $0.37
- Resistance Level
- VRAX $1.03
- AYRO $0.43
- Average True Range (ATR)
- VRAX 0.08
- AYRO 0.04
- MACD
- VRAX -0.00
- AYRO 0.01
- Stochastic Oscillator
- VRAX 24.46
- AYRO 55.67
About VRAX Virax Biolabs Group Limited
Virax Biolabs Group Ltd is a biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against world-wide viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes and Human Papillomavirus.
About AYRO AYRO Inc.
AYRO Inc designs and manufactures compact, sustainable electric vehicles for closed campus mobility, low-speed urban and community transport, local on-demand and last-mile delivery, and government use. It operates as one reportable segment, focusing on the manufacturing and sales of environmentally-conscious, minimal-footprint EVs.